Navidea Biopharma Reports Received FDA Feedback Related to Rheumatoid Arthritis Trial Design: FDA Said First Study, Phase 2b Trial, Is Aligned With Expectations For Studies, Will Continue To Work With Co. For Phase 3 Trial